Cencora (COR) — insider trading
Health Care
Cencora (COR) has 13 reported SEC Form 4 insider transactions in our data, including 3 open-market purchases among the most recent 13 (latest 2026-06-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Campbell Elizabeth S | Officer (Executive Vice President) | Grant / award / vesting | 50 | $240.53 | $12.0K | Form 4 |
| 2026-06-30 | Battaglia Silvana | Officer (Executive Vice President) | Grant / award / vesting | 58 | $240.53 | $14.0K | Form 4 |
| 2026-06-29 | Boratto Eva C | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 21,304 | — | — | Form 4 |
| 2026-06-22 | Tyler Lauren M | Director | Open-market purchase | 550 | $270.23 | $148.6K | Form 4 |
| 2026-06-18 | DURCAN DERMOT MARK | Director | Open-market purchase | 4,000 | $274.19 | $1.10M | Form 4 |
| 2026-05-28 | DURCAN DERMOT MARK | Director | Open-market purchase | 4,000 | $266.26 | $1.07M | Form 4 |
| 2026-05-01 | NALLY DENNIS M | Director | Grant / award / vesting | 116 | $304.00 | $35.3K | Form 4 |
| 2026-05-01 | Cooper Ellen | Director | Grant / award / vesting | 99 | $304.00 | $30.1K | Form 4 |
| 2026-05-01 | Tyler Lauren M | Director | Grant / award / vesting | 99 | $304.00 | $30.1K | Form 4 |
| 2026-04-01 | Krikorian Lazarus | Officer (SVP & Chief Accounting Officer) | Grant / award / vesting (derivative) | 3,936 | $0.00 | $0 | Form 4 |
| 2026-03-11 | Battaglia Silvana | Officer (Executive Vice President) | Option exercise / conversion (derivative) | 8,415 | $0.00 | $0 | Form 4 |
| 2026-03-11 | Battaglia Silvana | Officer (Executive Vice President) | Shares withheld for taxes / exercise cost | 3,673 | $350.30 | $1.29M | Form 4 |
| 2026-03-11 | Battaglia Silvana | Officer (Executive Vice President) | Option exercise / conversion | 8,415 | $0.00 | $0 | Form 4 |
Ask the chat about COR's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Cencora (COR).
Last updated 2026-06-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.